DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Hodge RJ, Lin J, Vasist Johnson LS, Gould EP, Bowers GD, Nunez DJ. SB-756050 Project Team.
Safety, pharmacokinetics, and pharmacodynamic effects of a selective TGR5 agonist, SB-756050, in type 2 diabetes.
Clin Pharmacol Drug Dev 2013;
2 (03) 213-222
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.